Emerging Issues in Pharmacological Management of Rheumatoid Arthritis: Results of a National Needs Assessment Survey Identifying Practice Variations for the Development of Canadian Rheumatology Association Clinical Practice Recommendations

REFERENCES

1. 1.↵
   1. O’Dell JR

   . Therapeutic strategies for rheumatoid arthritis. N Engl J Med 2004;350:2591–602.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Knevel R,
   2. Schoels M,
   3. Huizinga TW,
   4. Aletaha D,
   5. Burmester GR,
   6. Combe B,
   7. et al.

   Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2010;69:987–94.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Sanderson T,
   2. Morris M,
   3. Calnan M,
   4. Richards P,
   5. Hewlett S

   . Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care Res 2010;62:647–56.

   OpenUrlCrossRef
4. 4.↵
   1. Davis D,
   2. Goldman J,
   3. Palda VA

   . Canadian Medical Association handbook on clinical practice guidelines; 2007. [Internet; accessed Aug 18, 2011]. Available from: www.cma.ca/multimedia/CMA/content_images/ClinicalResources/PDF/English/CPGHandbook.pdf
5. 5.↵
   1. Harrison MB,
   2. Legare F,
   3. Graham ID,
   4. Fervers B

   . Adapting clinical practice guidelines to local context and assessing barriers to their use. CMAJ 2010;182:E78–84.

   OpenUrlFREE Full Text
6. 6.↵
   1. Bykerk V,
   2. Akhavan P,
   3. Hazlewood GS,
   4. Schieir O,
   5. Dooley A,
   6. Haraoui B,
   7. et al.

   Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. J Rheumatol 2011;38:1559–82.

   OpenUrl
7. 7.↵
   1. Bombardier C,
   2. Akhavan P,
   3. Hazlewood G,
   4. Schieir O,
   5. Dooley A,
   6. Haraoui B,
   7. et al.

   Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: Part II Safety. J Rheumatol 2011; (submitted).